Seminars in Oncology
Volume 32, Issue 3 , Pages 329-335 , June 2005

Redefining Bronchioloalveolar Carcinoma

  • Janessa J. Laskin

      Affiliations

    • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver, BC, Canada
    • Corresponding Author InformationAddress reprint requests to Janessa Laskin, MD, Division of Medical Oncology, BC Cancer Agency, 600 W 10th Ave, Vancouver, BC, V5Z 4E6 Canada
    • ,
  • Alan B. Sandler

      Affiliations

    • Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
    • ,
  • David H. Johnson

      Affiliations

    • Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN

References 

  1. Page NC , Read WL , Tierney RM , et al.   The epidemiology of small cell lung cancer . Proc Am Soc Clin Oncol . 2002;205a: (abstr 1216)
  2. Liebow AA . Bronchiolo-alveolar carcinoma . Adv Intern Med . 1960;10:329–358
  3. Travis WDC , Corrin B , et al.   Bronchioloalveolar carcinoma . TV In:  Travis WD ,  Colby TV , et al. editor. WHO International Histological Classification of Tumors . (ed 5). Berlin, Germany: Springer; 1999;p. 34–38
  4. Ebright MI , Zakowski MF , Martin J , et al.   Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma . Ann Thorac Surg . 2002;74:1640–1646
  5. Terasaki H , Niki T , Matsuno Y , et al.   Lung adenocarcinoma with mixed bronchioloalveolar and invasive components (Clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization) . Am J Surg Pathol . 2003;27:937–951
  6. Auerbach O , Garfinkel L . The changing pattern of lung carcinoma . Cancer . 1991;68:1973–1977
  7. Barsky SH , Cameron R , Osann KE , et al.   Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features . Cancer . 1994;73:1163–1170
  8. Travis WD , Lubin J , Ries L , et al.   United States lung carcinoma incidence trends (Declining for most histologic types among males, increasing among females) . Cancer . 1996;77:2464–2470
  9. Wingo PA , Ries LAG , Giovino GA , et al.   Annual Report to the Nation on the Status of Cancer, 1973–1996, With a Special Section on Lung Cancer and Tobacco Smoking . J Natl Cancer Inst . 1999;91:675–690
  10. Read WL , Page NC , Tierney RM , et al.   The epidemiology of bronchioloalveolar carcinoma over the past two decades (Analysis of the SEER database) . Lung Cancer . 2004;45:137–142
  11. Barkley JE , Green MR . Bronchioloalveolar carcinoma . J Clin Oncol . 1996;14:2377–2386
  12. Breathnach OS , Kwiatkowski DJ , Finkelstein DM , et al.   Bronchioloalveolar carcinoma of the lung (Recurrences and survival in patients with stage I disease) . J Thorac Cardiovasc Surg . 2001;121:42–47
  13. Breathnach OS , Ishibe N , Williams J , et al.   Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung . Cancer . 1999;86:1165–1173
  14. Morabia A , Wynder EL . Relation of bronchioloalveolar carcinoma to tobacco . BMJ . 1992;304:541–543
  15. Brownson RC , Loy TS , Ingram E , et al.   Lung cancer in nonsmoking women. Histology and survival patterns . Cancer . 1995;75:29–33
  16. Palmarini M , Fan H . Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer . J Natl Cancer Inst . 2001;93:1603–1614
  17. Yousem SA , Finkelstein SD , Swalsky PA , et al.   Absence of Jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis . Hum Pathol . 2001;32(10):1039–1042
  18. Cheng YW , Chiou HL , Sheu GT , et al.   The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women . Cancer Res . 2001;61:2799–2803
  19. Volpino P , D’Andrea N , Cangemi R , et al.   Bronchioloalveolar carcinoma: clinical, radiographic, and pathological findings. Surgical results . J Cardiovasc Surg . 2001;42:261–267
  20. Dumont P , Gasser B , Rouge C , et al.   Bronchoalveolar carcinoma (Histopathologic study of evolution in a series of 105 surgically treated patients) . Chest . 1998;113:391–395
  21. Liu YY , Chen YM , Huang MH , et al.   Prognosis and recurrent patterns in bronchioloalveolar carcinoma . Chest . 2000;118:940–947
  22. Regnard JF , Santelmo N , Romdhani N , et al.   Bronchioloalveolar lung carcinoma (results of surgical treatment and prognostic factors) . Chest . 1998;114:45–50
  23. Feldman ER , Eagan RT , Schaid DJ . Metastatic bronchioloalveolar carcinoma and metastatic adenocarcinoma of the lung (Comparison of clinical manifestations, chemotherapeutic responses, and prognosis) . Mayo Clin Proc . 1992;67:27–32
  24. Sorensen JB , Hirsch FR , Olsen J . The prognostic implication of histopathologic subtyping of pulmonary adenocarcinoma according to the classification of the World Health Organization. An analysis of 259 consecutive patients with advanced disease . Cancer . 1988;62:361–367
  25. Vance RB , Crowley J , Gandara D . Phase II evaluation of paclitaxel by 96-h infusion in stage IIIb and IV bronchioloalveolar carcinoma . 2000; Presented at the World Conference on Lung Cancer, Tokyo, Japan, Sept 11–15
  26. Kelly K , Crowley J , Bunn PA , et al.   Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer (A Southwest Oncology Group trial) . J Clin Oncol . 2001;19:3210–3218
  27. Schiller JH , Harrington D , Belani CP , et al.   Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer . N Engl J Med . 2002;346:92–98
  28. Scagliotti GV , De Marinis F , Rinaldi M , et al.   Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer . J Clin Onco . 2002;20:4285–4291
  29. Van Meerbeeck JP , Smit EF , Lianes P , et al.   An EORTC randomized phase III trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC) . Proc Am Soc Clin Oncol . 2001;308a: (abstr 1228)
  30. Salomon DS , Brandt R , Ciardiello F , et al.   Epidermal growth factor-related peptides and their receptors in human malignancies . Crit Rev Oncol Hematol . 1995;19:183–232
  31. Ritter CA , Arteaga CL . The epidermal growth factor receptor-tyrosine kinase (A promising therapeutic target in solid tumors) . Semin Oncol . 2003;30(suppl 1):3–11
  32. Rusch V , Klimstra D , Venkatraman E , et al.   Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression . Clin Cancer Res . 1997;3:515–522
  33. Fontanini G , De Laurentiis M , Vignati S , et al.   Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer (Amphiregulin and microvessel count are independent prognostic indicators of survival) . Clin Cancer Res . 1998;4:241–249
  34. Kris MG , Natale RB , Herbst RS , et al.   Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer (A randomized trial) . JAMA . 2003;290:2149–2158
  35. Fukuoka M , Yano S , Giaccone G , et al.   Multi-institutional randomized phase ii trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer . J Clin Oncol . 2003;21:2237–2246
  36. Perez-Soler R , Chachoua A , Hammond LA , et al.   Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer . J Clin Oncol . 2004;22:3238–3247
  37. Miller VA , Kris MG , Shah N , et al.   Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer . J Clin Oncol . 2004;22:1103–1109
  38. West H , Franklin WA , et al.   Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (Southwest Oncology Group Study S0126) . Proc Am Soc Clin Oncol . 2004;618: (abstr 7014)
  39. Kris M , Sandler A , Miller V , et al.   Cigarette smoking history predicts sensitivity to erlotinib (Resulsts of a phase II trial in patients with bronchioloalveolar carcinoma) . Proc Am Soc Clin Ocol . 2004;628: (abstr 7062)
  40. Miller VA , Patel J , Shah N , et al.   The epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) shows promising activity in patients with bronchioloalveolar cell carcinoma (BAC) (Preliminary results of a phase II trial) . Proc Am Soc Clin Oncol . 2003;619: (abstr 2491)
  41. Paez JG , Janne PA , Lee JC , et al.   EGFR mutations in lung cancer (Correlation with clinical response to gefitinib therapy) . Science . 2004;304:1497–1500
  42. Lynch TJ , Bell DW , Sordella R , et al.   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib . N Engl J Med . 2004;350:2129–2139
  43. Perez-Soler R . The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancer . Clin Cancer Res . 2004;10(suppl):4238s–4240s
  44. Bailey LR , Janas M , Bindslev N , et al.   Evaluation of epidermal growth factor receptor (EGFR) as a predictive marker in patients with non-small-cell lung cancer (NSCLC) receiving first-line gefitinib combined with platinum-based chemotherapy . Proc Am Soc Clin Oncol . 2004;618: (abstr 7013)
  45. Franklin WA , Gumerlock PH , Crowley J , et al.   EGFR, HER2 and ERB-B pathway activation in bronchioloalveolar carcinoma (BAC) (Analysis of SWOG 9417 and lung SPORE tissue samples) . Proc Am Soc Clin Oncol . 2003;620: (abstr 2493)
  46. Hirsch FR , Varella-Garcia M , Bunn PA , et al.   Epidermal growth factor receptor in non-small-cell lung carcinomas (Correlation between gene copy number and protein expression and impact on prognosis) . J Clin Oncol . 2003;21:3798–3807
  47. Hirsch FR , Scagliotti GV , Langer CJ , et al.   Epidermal growth factor family of receptors in preneoplasia and lung cancer (Perspectives for targeted therapies) . Lung Cancer . 2003;41(suppl 1):S29–S42
  48. Laskin JG , Zubkus J , et al.   Bronchioloalveolar carcinoma (Clinical characteristics and tissue microarray patterns, in World Conference on Lung Cancer) . A Lung Cancer . 2003;41(suppl):144
  49. Cappuzzo F , Magrini E , Bartolini S , et al.   Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer . Proc Am Soc Clin Oncol . 2004;196: (abstr 3004)

PII: S0093-7754(05)00083-7

doi: 10.1053/j.seminoncol.2005.02.013

Seminars in Oncology
Volume 32, Issue 3 , Pages 329-335 , June 2005

Article Tools